GNH USA

Europe — EMA

Ondansetron Kalceks

Ondondansetron, the active ingredient in Ondansetron Kalceks, is a 5-HT3 receptor antagonist presented as a 5 mg tablet for oral use. It treats and prevents nausea and vomiting associated with chemotherapy, radiation…

Request sourcing

1
Pack/s

What is Ondansetron?

Ondondansetron, the active ingredient in Ondansetron Kalceks, is a 5-HT3 receptor antagonist presented as a 5 mg tablet for oral use. It treats and prevents nausea and vomiting associated with chemotherapy, radiation therapy, and surgery in adult patients.

GNH USA supplies Ondansetron Kalceks as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Ondansetron used for?

Ondansetron Kalceks is a selective   ...  ...  ...  ...  ...  ... ...  ...  ...  …  … ...  …  …  …  …  … - Chemotherapy‑induced nausea and  …  …  ...  ... ...  ... ... … … … … … … … … … … … -   … … …  ...  ...  ...  ...  ...  … … … … … … … … -  ... … … … … … … … … … … … … … … … - …  … … … …  … … … … ... … … … … … … 

What are the side effects of Ondansetron?

Ondansetron         … … … … … 

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Ondansetron
Route
Intramuscular Use , Intravenous Use
Manufacturer
Kalceks
Origin
EU

Related products